Eculizumab allows plasma exchange iscontinuation after a third kidney transplantation in a patient with plasma dependent atypical HUS due to CFH mutation

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Author(s): Knobbe I, Bouts A, Groothoff J, Strain L, Goodship T, Davin JC

Publication type: Conference Proceedings (inc. Abstract)

Publication status: Published

Conference Name: 42nd Annual Scientific Meeting of the European Society for Paediatric Nephrology - A Joint Meeting with the Renal Association

Year of Conference: 2009

Pages: 1881-1881

ISSN: 0931-041X

Publisher: Pediatric Nephrology: Springer

URL: http://dx.doi.org/10.1007/s00467-009-1250-6

DOI: 10.1007/s00467-009-1250-6

Notes: Abstract number SAT-M-136

Library holdings: Search Newcastle University Library for this item

ISBN:

ePrints